Study Links Type 2 Diabetes to Higher Risk of Hearing Loss

Translate to Spanish or other 102 languages!

A recent review highlights hearing loss as a hidden, yet common, complication of diabetes. Image for illustration purposes.
A recent review highlights hearing loss as a hidden, yet common, complication of diabetes. Image for illustration purposes. 
- Advertisement -

Medical News Today

Diabetes is well known to increase the risk of complications throughout the body, potentially affecting the eyes, kidneys, and nerves. 

As a result, people with diabetes are routinely monitored for conditions such as diabetic retinopathy, kidney disease, and neuropathy. This ongoing care can help prevent severe problems, such as sight loss, kidney damage, and nerve damage.

- Advertisement -

Follow the link below to Medical Nesw Today to read the full story:

https://www.medicalnewstoday.com/articles/1-in-4-adults-type-2-diabetes-experience-hearing-loss?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-07-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AACT NOW to Launch Rally the Vote Across Rio Grande Valley

The Advocacy Alliance Center of Texas, known as AACT NOW, will officially launch its Rally the Vote initiative Thursday, Oct. 1, bringing together community partners working to expand access to accurate, nonpartisan election information across the Rio Grande Valley.

STHS and Prominence Health Empower Seniors This World Heart Day

World Heart Day serves as a powerful reminder that cardiovascular disease remains one of the greatest threats to the health and well-being of older adults.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.
- Advertisement -